These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8496861)

  • 1. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
    Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
    J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.
    Tam LS; Li EK; Lam CW; Tomlinson B
    Lupus; 2000; 9(6):413-6. PubMed ID: 10981644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ; Campos H; Moye LA; Sacks FM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):853-8. PubMed ID: 12637336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
    Borba EF; Bonfá E
    J Rheumatol; 2001 Apr; 28(4):780-5. PubMed ID: 11327250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus.
    Sari RA; Polat MF; Taysi S; Bakan E; Capoğlu I
    Clin Rheumatol; 2002 Nov; 21(6):520-4. PubMed ID: 12447639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.
    Tam LS; Gladman DD; Hallett DC; Rahman P; Urowitz MB
    J Rheumatol; 2000 Sep; 27(9):2142-5. PubMed ID: 10990225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
    Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
    HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus.
    Lilleby V; Haugen M; Mørkrid L; Frey Frøslie K; Holven KB; Førre O
    Scand J Rheumatol; 2007; 36(1):40-7. PubMed ID: 17454934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
    Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
    Ilowite NT; Copperman N; Leicht T; Kwong T; Jacobson MS
    J Rheumatol; 1995 Jul; 22(7):1347-51. PubMed ID: 7562770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of hydroxychloroquine on metabolism of serum lipids and left ventricular structure and function in patients of systemic lupus erythematosus].
    Meng J; Lu Y; Dong X; Liu H
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):965-8. PubMed ID: 24851679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
    Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
    Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
    Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.